San Diego, CA, United States of America

Zachary Owyang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zachary Owyang: Innovator in Pharmaceutical Compositions

Introduction

Zachary Owyang is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His innovative work focuses on the use of WRN helicase inhibitors, which have potential applications in treating proliferative diseases such as cancer.

Latest Patents

Zachary Owyang holds a patent for "Pharmaceutical compositions comprising WRN helicase inhibitors." This patent discloses compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof, wherein R, R, X, Y, Z, and W are defined within the patent. The compounds are recognized as inhibitors of WRN helicase, making them useful in the treatment of various proliferative diseases, including cancer. He has 1 patent to his name.

Career Highlights

Zachary Owyang is currently employed at Vividion Therapeutics, Inc., where he continues to advance his research in pharmaceutical innovations. His work at Vividion Therapeutics has positioned him as a key player in the development of novel therapeutic strategies.

Collaborations

Zachary collaborates with talented individuals in his field, including Shota Kikuchi and Betty Lam. These collaborations enhance the research environment and contribute to the advancement of their shared goals in pharmaceutical development.

Conclusion

Zachary Owyang is a dedicated inventor whose work in pharmaceutical compositions has the potential to impact the treatment of serious diseases. His innovative approach and collaboration with other professionals in the field underscore his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…